Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Encephalitis

fingolimod hydrochloride has been researched along with Encephalitis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's8 (80.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
He, J; Lin, L; Qin, C; Shang, K; Tian, DS; Wang, W; Wu, LJ; Yang, LL; Zhan, KB; Zhou, LQ; Zou, J1
Bharatha, A; Rotstein, DL; Selchen, D1
Cho, SM; DeRosa, SG; Ferreira, NS; Furness, AM; Futerman, AH; Gao, D; Grishchuk, Y; Herron, SS; Medina, DL; Mepyans, ME; Sankar, SB; Scotto Rosato, A; Slaugenhaupt, SA; Smith, SS; Vardi, A; Weinstock, LD; Wood, LB1
Erdogmus, UA; Kamisli, O; Kamisli, S; Özcan, C; Tecellioglu, M1
Lovera, J; Villemarette-Pittman, N1
Fichman-Horn, S; Hellmann, MA; Inbar, E; Lev, N; Lotan, I; Luckman, J; Mosberg-Galili, R; Steiner, I; Yakimov, M1
Albert-Weissenberger, C; Hennig, N; Hopp, S; Kleinschnitz, C; Mencl, S; Schuhmann, MK; Sirén, AL1
Bester, M; Gerloff, C; Heesen, C; Leypoldt, F; Moeller, F; Münchau, A1
Agoropoulou, C; Burtin, P; Calabresi, P; de Vera, A; Francis, G; Hohlfeld, R; Holdbrook, F; Kappos, L; Mueller-Lenke, N; O'Connor, P; Polman, CH; Radue, EW; Selmaj, K; Zhang-Auberson, L1
Gao, F; Jiang, W; Li, X; Liu, Y; Wang, Y; Wei, D1

Trials

1 trial(s) available for fingolimod hydrochloride and Encephalitis

ArticleYear
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
    Archives of neurology, 2012, Volume: 69, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Brain; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Encephalitis; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; International Cooperation; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Propylene Glycols; Sphingosine; Time Factors; Young Adult

2012

Other Studies

9 other study(ies) available for fingolimod hydrochloride and Encephalitis

ArticleYear
Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization.
    Brain research, 2020, 01-01, Volume: 1726

    Topics: Angiogenesis Inducing Agents; Animals; Brain; Brain Ischemia; Encephalitis; Fingolimod Hydrochloride; Male; Mice, Inbred C57BL; Microglia; Neovascularization, Physiologic; Neuroprotective Agents

2020
Severe aseptic temporal lobe encephalitis on fingolimod.
    Multiple sclerosis and related disorders, 2018, Volume: 23

    Topics: Encephalitis; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Temporal Lobe

2018
Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV.
    Human molecular genetics, 2018, 08-01, Volume: 27, Issue:15

    Topics: Animals; Astrocytes; Brain; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalitis; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Lysosomal Membrane Proteins; Male; Mice, Knockout; Mucolipidoses; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Transient Receptor Potential Channels

2018
Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis during fingolimod therapy.
    Multiple sclerosis and related disorders, 2019, Volume: 27

    Topics: Adult; Brain; Encephalitis; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Listeria monocytogenes; Listeriosis; Multiple Sclerosis

2019
Tumefactive multiple sclerosis and fingolimod.
    Journal of the neurological sciences, 2014, Sep-15, Volume: 344, Issue:1-2

    Topics: Brain Injuries; Encephalitis; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Occipital Lobe; Propylene Glycols; Sphingosine

2014
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.
    Journal of the neurological sciences, 2014, Sep-15, Volume: 344, Issue:1-2

    Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain Injuries; Encephalitis; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Occipital Lobe; Propylene Glycols; Sphingosine

2014
FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation.
    Journal of neuroimmunology, 2014, Sep-15, Volume: 274, Issue:1-2

    Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Encephalitis; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Lymphopenia; Mice; Mice, Inbred C57BL; Propylene Glycols; Signal Transduction; Sphingosine; T-Lymphocytes; Treatment Outcome

2014
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
    Neurology, 2009, Mar-17, Volume: 72, Issue:11

    Topics: Adult; Brain; Cerebral Hemorrhage; Contrast Media; Encephalitis; Epilepsy, Complex Partial; Female; Fingolimod Hydrochloride; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Necrosis; Propylene Glycols; Sphingosine

2009
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 103, Issue:2

    Topics: Animals; Astrocytes; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Hippocampus; Immunohistochemistry; Interleukin-1beta; Lithium Compounds; Male; Pilocarpine; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine; Status Epilepticus; Tumor Necrosis Factor-alpha

2012